Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: A study of 86 cases

Gynecologic Oncology

Volumn 128, Issue 2, 2013, Pages 322-326

  Lim, D ^a   Wang, W L ^b   Lee, C H ^c   Dodge, T ^c   Gilks, B ^c   Oliva, E ^d  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

FIGO; Leiomyosarcoma; Staging; Survival; Uterus

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; UTERUS SARCOMA;

FEMALE; HUMANS; LEIOMYOSARCOMA; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 84872831621     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.11.009     Document Type: Article

References (56)

1. L. Benoit, L. Arnould, N. Cheynel, S. Goui, F. Collin, and J. Fraisse The role of surgery and treatment trends in uterine sarcoma Eur J Surg Oncol 31 2005 434 442 (Pubitemid 40521313)
2. L. Chauveinc, E. Deniaud, C. Plancher, X. Sastre, F. Amsani, and A. de la Rochefordiere Uterine sarcomas: the Curie Institute experience. Prognosis factors and adjuvant treatments Gynecol Oncol 72 1999 232 237 (Pubitemid 29093780)
3. D.S. Kapp, J.Y. Shin, and J.K. Chan Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy Cancer 112 2008 820 830 (Pubitemid 351240576)
4. L. Livi, F. Paiar, E. Meldolesi, G. Simontacchi, G. Amunni, and R. Barca Treatment of uterine sarcoma at the University of Florence from 1980-2001 Tumori 91 2005 139 143 (Pubitemid 40705086)
5. P. Pautier, C. Genestie, A. Rey, P. Morice, B. Roche, and C. Lhomme Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma Cancer 88 2000 1425 1431 (Pubitemid 30155181)
6. G. El Husseiny, N. Al Bareedy, W.A. Mourad, G. Mohamed, M. Shoukri, and J. Subhi Prognostic factors and treatment modalities in uterine sarcoma Am J Clin Oncol 25 2002 256 260 (Pubitemid 34602546)
7. F.J. Major, J.A. Blessing, S.G. Silverberg, C.P. Morrow, W.T. Creasman, and J.L. Currie Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study Cancer 71 1993 1702 1709 (Pubitemid 23056094)
8. M.M. Leitao, Y. Sonoda, M.F. Brennan, R.R. Barakat, and D.S. Chi Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus Gynecol Oncol 91 2003 209 212 (Pubitemid 37188613)
9. B.A. Goff, L.W. Rice, D. Fleischhacker, H.G. Muntz, S.S. Falkenberry, and N. Nikrui Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence Gynecol Oncol 50 1993 105 109 (Pubitemid 23235520)
10. R. Bernstein-Molho, D. Grisaro, V. Soyfer, T. Safra, and O. Merimsky Metastatic uterine leiomyosarcomas: a single-institution experience Int J Gynecol Cancer 20 2010 255 260
11. J. Prat FIGO staging for uterine sarcomas Int J Gynaecol Obstet 104 2009 177 178
12. O. Zivanovic, M.M. Leitao, A. Iasonos, L.M. Jacks, Q. Zhou, and N.R. Abu-Rustum Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee On Cancer Staging Systems J Clin Oncol 27 2009 2066 2072
13. P.G. Rose, M.S. Piver, Y. Tsukada, and T. Lau Patterns of metastasis in uterine sarcoma. An autopsy study Cancer 63 1989 935 938 (Pubitemid 19063205)
14. R. Blom, C. Guerrieri, O. Stal, H. Malmstrom, and E. Simonsen Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases Gynecol Oncol 68 1998 54 61 (Pubitemid 28109824)
15. S.E. Brooks, M. Zhan, T. Cote, and C.R. Baquet Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol Oncol 93 2004 204 208 (Pubitemid 38429571)
16. A. Gadducci, F. Landoni, E. Sartori, P. Zola, T. Maggino, and A. Lissoni Uterine leiomyosarcoma: analysis of treatment failures and survival Gynecol Oncol 62 1996 25 32 (Pubitemid 26234541)
17. R.L. Giuntoli II, D.S. Metzinger, C.S. DiMarco, S.S. Cha, J.A. Sloan, and G.L. Keeney Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy Gynecol Oncol 89 2003 460 469 (Pubitemid 36687793)
18. M. Nola, D. Babic, J. Ilic, M. Marusic, B. Uzarevic, and M. Petrovecki Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus Cancer 78 1996 2543 2550 (Pubitemid 26415687)
19. R.R. Nordal, G.B. Kristensen, J. Kaern, A.E. Stenwig, E.O. Pettersen, and C.G. Trope The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma Acta Oncol 34 1995 797 802
20. M. Pelmus, F. Penault-Llorca, L. Guillou, F. Collin, G. Bertrand, and M. Trassard Prognostic factors in early-stage leiomyosarcoma of the uterus Int J Gynecol Cancer 19 2009 385 390
21. A.H. Wolfson, D.J. Wolfson, S.Y. Sittler, L. Breton, A.M. Markoe, and J.G. Schwade A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas Gynecol Oncol 52 1994 56 62 (Pubitemid 24066853)
22. L.A. Aaro, R.E. Symmonds, and M.B. Dockerty Sarcoma of the uterus. A clinical and pathologic study of 177 cases Am J Obstet Gynecol 94 1966 101 109
23. E.V. Hannigan, and L.G. Gomez Uterine leiomyosarcoma Am J Obstet Gynecol 134 1979 557 564
24. G.B. Gard, N.J. Mulvany, and M.A. Quinn Management of uterine leiomyosarcoma in Australia Aust N Z J Obstet Gynaecol 39 1999 93 98 (Pubitemid 29108194)
25. K. Mayerhofer, A. Obermair, G. Windbichler, E. Petru, A. Kaider, and L. Hefler Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases Gynecol Oncol 74 1999 196 201 (Pubitemid 29377212)
26. W.A. Peters III, D.R. Howard, W.A. Andersen, and D.C. Figge Uterine smooth-muscle tumors of uncertain malignant potential Obstet Gynecol 83 1994 1015 1020 (Pubitemid 24165400)
27. T. Van Dinh, and J.D. Woodruff Leiomyosarcoma of the uterus Am J Obstet Gynecol 144 1982 817 823 (Pubitemid 13196596)
28. K.V. Kahanpaa, T. Wahlstrom, P. Grohn, E. Heinonen, U. Nieminen, and O. Widholm Sarcomas of the uterus: a clinicopathologic study of 119 patients Obstet Gynecol 67 1986 417 424 (Pubitemid 16129989)
29. B. Larson, C. Silfversward, B. Nilsson, and F. Pettersson Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981 Acta Oncol 29 1990 185 191 (Pubitemid 20145283)
30. C.P. Raut, M.R. Nucci, Q. Wang, J. Manola, M.M. Bertagnolli, and G.D. Demetri Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma Eur J Cancer 45 2009 2818 2824
31. O. Zivanovic, L.M. Jacks, A. Iasonos, M.M. Leitao Jr., R.A. Soslow, and E. Veras A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma Cancer 118 2012 660 669
32. O. Fadare, M.R. Mariappan, D. Hileeto, S. Wang, J.N. McAlpine, and D.L. Rimm Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer Mod Pathol 18 2005 673 680 (Pubitemid 40676379)
33. J.P. Orezzoli, S. Sioletic, A. Olawaiye, E. Oliva, and M.G. del Carmen Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion Gynecol Oncol 113 2009 316 323
34. K. Kokawa, K. Nishiyama, M. Ikeuchi, Y. Ihara, N. Akamatsu, and T. Enomoto Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003) Int J Gynecol Cancer 16 2006 1358 1363 (Pubitemid 43886769)
35. W.L. Wang, R. Soslow, M. Hensley, H. Asad, G.F. Zannoni, and M. de Nictolis Histopathologic prognostic factors in stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases Am J Surg Pathol 35 2011 522 529
36. E. Veras, O. Zivanovic, L. Jacks, D. Chiappetta, M. Hensley, and R. Soslow "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogeneous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas Am J Surg Pathol 35 2011 1626 1637
37. V.M. Abeler, O. Royne, S. Thoresen, H.E. Danielsen, J.M. Nesland, and G.B. Kristensen Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients Histopathology 54 2009 355 364
38. G. Garg, J.P. Shah, S. Kumar, C.S. Bryant, A. Munkarah, and R.T. Morris Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes Int J Gynecol Cancer 20 2010 888 894
39. P.S. Tan, E. Koh, C. Pang, W.S. Ong, L. Ngo, and L.T. Soh Uterine leiomyosarcoma in Asian patients: validation of the revised federation of gynecology and obstetrics staging system and identification of prognostic classifiers Oncologist 17 2012 1286 1293
40. S.G. Silverberg Leiomyosarcoma of the uterus. A clinicopathologic study Obstet Gynecol 38 1971 613 628
41. T.A. Dinh, E.A. Oliva, A.F. Fuller Jr., H. Lee, and A. Goodman The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital Gynecol Oncol 92 2004 648 652 (Pubitemid 38183158)
42. M.J. Marchese, A.S. Liskow, C.P. Crum, R.M. McCaffrey, and H.C. Frick II Uterine sarcomas: a clinicopathologic study, 1965-1981 Gynecol Oncol 18 1984 299 312 (Pubitemid 14095029)
43. K.J. Van Zee, D.M. Manasseh, J.L. Bevilacqua, S.K. Boolbol, J.V. Fey, and L.K. Tan A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 2003 1140 1151 (Pubitemid 40486808)
44. I. Ouzaid, D.R. Yates, V. Hupertan, P. Mozer, E. Chartier-Kastler, and A. Haertig A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy Prostate 72 2012 1200 1206
45. B.A. Goff, D. Kato, R.A. Schmidt, M. Ek, J.A. Ferry, and H.G. Muntz Uterine papillary serous carcinoma: patterns of metastatic spread Gynecol Oncol 54 1994 264 268 (Pubitemid 24301898)
46. K. Bodner, B. Bodner-Adler, O. Kimberger, K. Czerwenka, S. Leodolter, and K. Mayerhofer Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study J Reprod Med 48 2003 95 100 (Pubitemid 36249753)
47. G. Sutton, J.A. Blessing, and J.H. Malfetano Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study Gynecol Oncol 62 1996 226 229 (Pubitemid 26274804)
48. M.L. Hensley, R. Maki, E. Venkatraman, G. Geller, M. Lovegren, and C. Aghajanian Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial J Clin Oncol 20 2002 2824 2831 (Pubitemid 34651511)
49. R. Belgrad, N. Elbadawi, and P. Rubin Uterine sarcoma Radiology 114 1975 181 188
50. H.A. Gilbert, A.R. Kagan, L. Lagasse, M.R. Jacobs, and K. Tawa The value of radiation therapy in uterine sarcoma Obstet Gynecol 45 1975 84 88
51. P.G. Rose, J.G. Boutselis, and L. Sachs Adjuvant therapy for stage I uterine sarcoma Am J Obstet Gynecol 156 1987 660 662 (Pubitemid 17053041)
52. N.S. Reed, C. Mangioni, H. Malmstrom, G. Scarfone, A. Poveda, and S. Pecorelli Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874) Eur J Cancer 44 2008 808 818
53. O.M. Salazar, T.A. Bonfiglio, S.F. Patten, B.E. Keller, M. Feldstein, and M.E. Dunne Uterine sarcomas: natural history, treatment and prognosis Cancer 42 1978 1152 1160 (Pubitemid 9054573)
54. M. George, M.H. Pejovic, and A. Kramar Uterine sarcomas: prognostic factors and treatment modalities - study on 209 patients Gynecol Oncol 24 1986 58 67 (Pubitemid 16104357)
55. A.L. Covens, J.A. Nisker, W.B. Chapman, and H.H. Allen Uterine sarcoma: an analysis of 74 cases Am J Obstet Gynecol 156 1987 370 374 (Pubitemid 17020493)
56. J.B. Wheelock, H.B. Krebs, V. Schneider, and D.R. Goplerud Uterine sarcoma: analysis of prognostic variables in 71 cases Am J Obstet Gynecol 151 1985 1016 1022 (Pubitemid 15039769)